P

Palleon Pharmaceuticals

40 employees

Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.

Basic info

Industry

biotechnology research

Sectors

Glyco-Immune Checkpoint Inhibitors
Biotechnology
Health Care
Immuno-Oncology
Pharmaceutical
Clinical Development

Date founded

2016

Funding rounds raised

Total raised

$100M

from 7 investors over 7 rounds

P

Palleon Pharmaceuticals raised $100M on September 17, 2020

Investors: Takeda UK Limited, S.R. One Ltd, Surveyor Capital and Vertex Ventures HC

P

Palleon Pharmaceuticals raised $48M on October 4, 2017

Investors: Vertex Ventures HC, Takeda UK Limited and S.R. One Ltd

FAQ